Apollon is a South Korean medtech company developing a needle-free continuous glucose monitor that measures glucose through the skin using Raman spectroscopy, isolating glucose-specific wavelength bands to shrink the wearable device (Moglu) to roughly half the size of a smartphone. With teams in Seoul and Boston, it validated accuracy in a joint clinical study with MIT's Laser Biomedical Research Center published in the Journal of Diabetes Science and Technology, won a CES 2025 Innovation Award for Moglu, and holds 21 granted patents (17 US) out of 54 filings. Its Series A was led by SBI Investment with strategic backing from Naver and Daewoong, following a KRW 2.3 billion pre-Series A in 2024.
1
Round
1
Industry
3
Tags
Sep 23, 2026
Latest raise
Funding activity · 1 round
Sep 23, 2026
KRW 5B
Series A
Led by SBI Investment
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
